![Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial - The Lancet Infectious Diseases Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/d15bf779-8ede-4592-8521-1a1e7742dc52/gr1.gif)
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial - The Lancet Infectious Diseases
![The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis | Journal of Aerosol Medicine and Pulmonary Drug Delivery The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis | Journal of Aerosol Medicine and Pulmonary Drug Delivery](https://www.liebertpub.com/cms/10.1089/jamp.2017.1415/asset/images/medium/figure1.gif)
The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis | Journal of Aerosol Medicine and Pulmonary Drug Delivery
![The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis - The Lancet Respiratory Medicine The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/c4c5c423-96eb-431a-8421-6572ba6eec5c/gr1.gif)
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis - The Lancet Respiratory Medicine
![Antibiotics | Free Full-Text | Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives Antibiotics | Free Full-Text | Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives](https://www.mdpi.com/antibiotics/antibiotics-10-00338/article_deploy/html/images/antibiotics-10-00338-g001-550.jpg)
Antibiotics | Free Full-Text | Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
![Inhaled Antibiotics Market Size & Trends 2021 - expected to reach US$ 1,784.9 Mn With CAGR of 6.3% by 2027 | Coherent Market Insights | Medgadget Inhaled Antibiotics Market Size & Trends 2021 - expected to reach US$ 1,784.9 Mn With CAGR of 6.3% by 2027 | Coherent Market Insights | Medgadget](https://www.medgadget.com/wp-content/uploads/2021/06/inhaled-antibiotics-market-scaled.jpg)
Inhaled Antibiotics Market Size & Trends 2021 - expected to reach US$ 1,784.9 Mn With CAGR of 6.3% by 2027 | Coherent Market Insights | Medgadget
![Continuous alternating inhaled antibiotics for chronic pseudomonal infection in cystic fibrosis - ScienceDirect Continuous alternating inhaled antibiotics for chronic pseudomonal infection in cystic fibrosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1569199316300509-gr1.jpg)
Continuous alternating inhaled antibiotics for chronic pseudomonal infection in cystic fibrosis - ScienceDirect
![Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis - Meng-Jiao Xu, Bing Dai, 2020 Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis - Meng-Jiao Xu, Bing Dai, 2020](https://journals.sagepub.com/cms/10.1177/1753466620936866/asset/images/large/10.1177_1753466620936866-fig9.jpeg)
Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis - Meng-Jiao Xu, Bing Dai, 2020
![Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis - Marina Blanco-Aparicio, Jesús Luis Saleta Canosa, Paz Valiño López, María Teresa Martín Egaña, Iria Vidal García, Carmen Montero Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis - Marina Blanco-Aparicio, Jesús Luis Saleta Canosa, Paz Valiño López, María Teresa Martín Egaña, Iria Vidal García, Carmen Montero](https://journals.sagepub.com/cms/10.1177/1479973119872513/asset/images/large/10.1177_1479973119872513-fig1.jpeg)